CI monthly performance report
Explore CI's monthly returns, drawdown, and seasonality trends — updated every month.
CI monthly report
—
Key takeaways
- Cigna (CI) closed October 2026 at $271.29, down 0.20% for the month and −12.77% over the trailing 12 months.
- Year-to-date, CI is −1.43%, underperforming the S&P 500 which has returned +13.62% YTD.
- The stock is trading −3.04% versus its 200-day moving average ($279.81), a cautious technical signal.
- Over the past three years, CI has underperformed the S&P 500 by −87.45%, with a relative strength index reading of 52.1.
- Win rate over the trailing 39 months stands at 48.7% — 19 positive months versus 20 negative months.
Cigna ended October 2026 at $271.29, posting a monthly return of −0.20%. The S&P 500 returned +1.60% over the same window, leaving relative performance at −1.80%.
The current quarter stands at −0.20% (Q4 2026 (QTD)), while medium-term trend remains soft: price is −3.04% versus the 200-day moving average ($279.81).
Year-to-date, CI is −1.43% against SPY +13.62%, a gap of −15.06%. The stock is currently −14.00% below its 52-week high, with maximum 3-year drawdown at −33.38%.
| Period | CI | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.28% | +0.67% | −0.39% |
| 1 Week | −0.20% | +1.20% | −1.40% |
| 1 Month | −0.20% | +1.60% | −1.80% |
| 3 Months | −2.09% | +4.03% | −6.12% |
| 6 Months | +3.56% | +22.61% | −19.04% |
| YTD | −1.43% | +13.62% | −15.06% |
| 12 Months | −12.77% | +15.78% | −28.55% |
| 3 Years | −4.93% | +82.53% | −87.45% |
| Rank | Month | Return |
|---|---|---|
| #1 | Dec 2023 | +13.91% |
| #2 | Nov 2025 | +13.45% |
| #3 | Aug 2025 | +12.53% |
| #4 | Feb 2024 | +11.69% |
| #5 | Apr 2026 | +8.93% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2025 | −19.12% |
| #2 | Dec 2024 | −18.25% |
| #3 | Oct 2025 | −15.21% |
| #4 | Nov 2023 | −14.98% |
| #5 | Oct 2024 | −9.13% |
| Quarter | Return |
|---|---|
| Q3 2025 | −12.80% |
| Q4 2025 | −4.52% |
| Q1 2026 | −3.08% |
| Q2 2026 | +3.35% |
| Q3 2026 | −1.40% |
| Q4 2026 (QTD) | −0.20% |
| Year | Return |
|---|---|
| 2023 | −9.62% |
| 2024 | −7.78% |
| 2025 | −0.33% |
| 2026 | −1.43% |
| Metric | Value |
|---|---|
| 52-Week High | $315.47 (2025-10-03) |
| 52-Week Low | $239.51 (2025-11-03) |
| Current Price | $271.29 |
| 200-Day Moving Average | $279.81 |
| Price vs 200DMA | −3.04% |
| 3-Year Maximum Drawdown | −33.38% (2025-10-31) |
| Current Drawdown from 52W High | −14.00% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 52.1 |
| 3-Year Excess Return vs S&P 500 | −87.45% |
| RS Peak | 110.1 (Nov 2023) |
| RS Trough | 51.5 (Sep 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was CI's return for this report period?
CI returned −0.20% in the latest monthly window ending 2026-10-05.
Has CI outperformed SPY year to date?
YTD CI: −1.43% vs SPY: +13.62%.
What is CI's 12-month return?
−12.77% over the trailing 12 months.
Is CI above or below its 200-day moving average?
Price is −3.04% versus 200DMA ($279.81).
What is the maximum drawdown in the 3-year window?
−33.38% on 2025-10-31.